These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37165158)

  • 1. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
    Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
    J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival.
    Vitali F; Wein A; Rath T; Eckstein M; Neufert C; Siebler J; Atreya R; Hartmann A; Hohenberger W; Weber K; Neurath MF; Grützmann R; Merkel S
    Int J Colorectal Dis; 2022 Feb; 37(2):381-391. PubMed ID: 34865179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis.
    Kobayashi K; Toritani K; Kimura H; Kawashima J; Goto K; Suwa Y; Ozawa M; Ishibe A; Watanabe J; Endo I
    Ann Surg Oncol; 2024 Nov; 31(12):7807-7819. PubMed ID: 39244515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological differentiation between sporadic and colitis-associated intestinal cancer in a nationwide study: A propensity-score-matched analysis.
    Uchino M; Ikeuchi H; Noguchi T; Okabayashi K; Futami K; Tanaka S; Ohge H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Kono T; Kobayashi H; Ajioka Y; Sugihara K; Ishihara S;
    J Gastroenterol Hepatol; 2024 May; 39(5):893-901. PubMed ID: 38273469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
    Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.
    Flores E; Mbachi C; Achebe I; Asotibe J; Palomera-Tejeda E; Vohra I; Udechukwu V; Kotwal V
    Int J Colorectal Dis; 2021 Apr; 36(4):701-708. PubMed ID: 33063223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage at Diagnosis and Survival of Colorectal Cancer With or Without Underlying Inflammatory Bowel Disease: A Population-based Study.
    Arhi C; Askari A; Nachiappan S; Bottle A; Arebi N; Athanasiou T; Ziprin P; Aylin P; Faiz O
    J Crohns Colitis; 2021 Mar; 15(3):375-382. PubMed ID: 32991688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer: A Systematic Review and Meta-analysis.
    Lu C; Schardey J; Zhang T; Crispin A; Wirth U; Karcz KW; Bazhin AV; Andrassy J; Werner J; Kühn F
    Ann Surg; 2022 Nov; 276(5):e319-e330. PubMed ID: 34913897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
    Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
    Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
    Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
    Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis.
    Yaeger R; Paroder V; Bates DDB; Capanu M; Chou J; Tang L; Chatila W; Schultz N; Hersch J; Kelsen D
    Clin Colorectal Cancer; 2020 Dec; 19(4):e151-e156. PubMed ID: 32798155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes After Colorectal Surgery in Patients with Ulcerative Colitis-Associated Colorectal Cancer Versus Sporadic Colorectal Cancer.
    Lin VA; Lohse R; Madsen MT; Fransgaard T; Remzi FH; Gögenur I
    Ann Surg Oncol; 2022 Apr; 29(4):2505-2512. PubMed ID: 34482452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcomes of IBD-associated versus sporadic colorectal cancer in modern era: a matched case-control study.
    Thicoïpé A; Laharie D; Smith D; Chabrun E; Rullier A; Poullenot F; Rullier E; Denost Q
    Int J Colorectal Dis; 2018 Jul; 33(7):963-966. PubMed ID: 29675590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.